Intestinal permeability and toxicity of second-line therapeutic agents in ovarian cancer

Tumori

Volumn 94, Issue 4, 2008, Pages 624-626

  Melichar, Bohuslav ^a   Hyšpler, Radomír ^a   Dragounová, Emanuela ^a   Kalábová, Hana ^a   Dvořák, Josef ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DISACCHARIDE; EPIRUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; GLUTAMINE; IRINOTECAN; LACTULOSE; MANNITOL; MONOSACCHARIDE; SUCROSE; TOPOTECAN; WATER; XYLOSE;

ADJUVANT THERAPY; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BREAST CARCINOMA; CAPILLARY GAS CHROMATOGRAPHY; CLINICAL FEATURE; COLORECTAL CARCINOMA; DEHYDRATION; DIET RESTRICTION; DRUG EFFICACY; DRUG PENETRATION; GALLBLADDER CARCINOMA; GASTROINTESTINAL TOXICITY; HUMAN; INTERVENTION STUDY; INTESTINE MUCOSA PERMEABILITY; INTESTINE OBSTRUCTION; LABORATORY TEST; LETTER; MEDICAL DECISION MAKING; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVARY CARCINOMA; OVARY METASTASIS; PATIENT MONITORING; PERITONEUM PSEUDOMYXOMA; URINARY EXCRETION; VITAMIN SUPPLEMENTATION;

EID: 54749092855     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400436     Document Type: Letter

References (5)

1. Li Y, Yu Z, Liu F, Tan L, Wu B, Li J: Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial. Tumori, 92: 396-401, 2006.
2. Melichar B, Urbanek L, Krcmova L, Kalabova H, Svobodova I, Dragounova E, Vesely P, Hyspler R, Solichova D: Urinary neopterin in patients with ovarian cancer. Pteridines, 17: 145-153, 2006.
3. Herzog TJ: Recurrent ovarian cancer: how important is it to treat disease progression? Clin Cancer Res, 10: 7439-7449, 2004.
4. Melichar B, Dvorak J, Hyspler R, Zadak Z: Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents. Chemotherapy, 51: 336-338, 2005.
5. Sukkar SG, Schenone E, Foppiani L, Nobile T: Experimental assessment of chemotherapy-induced early intestinal damage in colon cancer the lactulose-mannitol permeability test. Tumori, 90: 461-463, 2004.